Scott Tarriff, President and CEO at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 14,549 shares at $85.65 ($1.2M) on 2016-01-04, disclosed to the SEC on 2016-01-05.
Open-market sale of $1.2M EGRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.65 | 11,776 | $1.0M | 80.7% |
| 2 | $87.02 | 2,773 | $241K | 19.3% |
| Total | $85.91 avg | 14,549 | $1.2M | 100% |
| Filing → |
| EGRX | SELL | 2023-05-18 | $300K | — | Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-04-03 | $2.5M | — | Filing → |